| Medication treatments for schizophrenia: translating research findings into better outcomes. | |
| | |
MedLine Citation:
|
PMID: 15990533 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
The atypical or novel antipsychotics have advanced the treatment of schizophrenia, especially given their reduced extrapyramidal side effect liability. In this article, the authors examine a number of recently published or presented studies of the atypical antipsychotics, many of them post approval studies, that shed additional light on this class of medications. Clozapine stands alone as a medication for treatment-resistant schizophrenia, but the other first-line atypical agents appear to reduce relapse rates during maintenance treatment and to have less of a long-term risk for tardive dyskinesia. However, additional research is needed to distinguish the atypical antipsychotics from each other and to better understand their non-neurological side effects. |
| | |
Authors:
|
J Lauriello; J Bustillo |
Related Documents
:
|
12568943 - Effects of stimulant medications on the eeg of children with attention-deficit/hyperact... 12091263 - Sexual dysfunction in patients taking conventional antipsychotic medication. 9481103 - Teaching medical ethics in a medical college in india. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of psychiatric practice Volume: 7 ISSN: 1527-4160 ISO Abbreviation: J Psychiatr Pract Publication Date: 2001 Jul |
Date Detail:
|
Created Date: 2005-07-01 Completed Date: 2005-07-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100901141 Medline TA: J Psychiatr Pract Country: United States |
Other Details:
|
Languages: eng Pagination: 260-5 Citation Subset: - |
Affiliation:
|
Department of Psychiatry, University of New Mexico, Albuquerque 87131, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Seven keys to relapse prevention in schizophrenia.
Next Document: The bipolar spectrum and the antidepressant view of the world.